The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions - Report - MDSpire
Advertisement
The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions
Clinical Report: Impact of the C-reactive Protein-Triglyceride-Glucose Index on Heart Failure
Overview
The C-reactive protein-triglyceride-glucose index (CTI) is an independent prognostic marker for all-cause mortality in chronic heart failure patients across varying ejection fractions. Elevated CTI levels are associated with significantly increased mortality risk, particularly in patients with heart failure with reduced and mildly reduced ejection fractions.
Background
Heart failure (HF) is a major public health concern, with increasing prevalence and mortality rates globally. Identifying reliable prognostic markers is crucial for risk stratification and management of patients with HF. The CTI, which integrates inflammation and insulin resistance, may provide valuable insights into patient prognosis across different heart failure phenotypes.
Data Highlights
Parameter
Findings
Patients Included
1,130
CTI Levels
Higher levels associated with increased all-cause mortality
HFrEF Mortality Risk
Elevated CTI linked to higher mortality in HFrEF
HFmrEF Mortality Risk
Elevated CTI linked to higher mortality in HFmrEF
Key Findings
CTI is an independent prognostic marker for all-cause mortality in CHF patients.
Patients with elevated CTI levels have a significantly higher risk of mortality.
Subgroup analysis shows elevated CTI is particularly concerning in HFrEF and HFmrEF patients.
CTI combines assessments of inflammation and insulin resistance, relevant in HF prognosis.
CTI may aid in risk stratification and management decisions in clinical practice.
Clinical Implications
Clinicians should consider incorporating CTI into routine assessments for patients with chronic heart failure to enhance prognostic accuracy. Monitoring CTI levels may help identify patients at higher risk for adverse outcomes, guiding more tailored therapeutic strategies.
Conclusion
The CTI serves as a valuable prognostic tool in chronic heart failure, indicating increased mortality risk across various ejection fractions. Its integration into clinical practice may improve patient management and outcomes.
